DJIA 17,959.44 154.64 0.87%
NASDAQ 4,781.42 16.04 0.34%
S&P 500 2,078.54 7.89 0.38%
market minute promo

Johnson & Johnson (NYSE: JNJ)



company name or ticker
Company Photos
(Click to zoom)

AbbVie's All-Oral, Interferon-Free HCV Treatment Approved - Analyst Blog

Celgene Gets Positive CHMP Recommendation for Revlimid - Analyst Blog

Johnson & Johnson's Immunology Pipeline Is Golden

A Victory For Express Scripts And AbbVie At The Expense Of Gilead Sciences, J&J And... Oh Yeah, Pati

A Victory For Express Scripts And AbbVie At The Expense Of Gilead Sciences, J&J And... Oh Yeah, Patients

3 Proven Ways to Increase Your Income in Retirement

Three Motley Fool analysts offer advice on how retirees can boost their income.

The Most Disappointing Clinical Failures in 2014

Three Motley Fool contributors tell us what they think were the biggest drug trial failures this year.

The 3 Best Stocks to Own in Retirement

Three Motley Fool contributors offer insight into which stocks are right for retirees.

3 Large Cap Biotech Stocks That Could Surprise Investors in 2015

Celgene Corp, Biogen Idec, and Medivation Inc. offer catalysts that could allow them to outpace estimates next year.

Could the Next Generation of Diabetes Treatments Be Found in This Illegal Drug?

Diabetes affects more than 29 million Americans and can lead to a number of serious complications. However, this currently illegal drug could provide a new pathway for diabetics to achieve better glycemic balance.

These Biotech Stocks Are Growing Even Faster Than Gilead Sciences

Medivation Inc. and Pharmacyclics are posting even faster revenue growth than Gilead Sciences.
See More Articles...